These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8684503)

  • 21. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
    Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H
    Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R; Corà F; Laveder F; Cavallo M; Busato A; Rigoli AM
    Minerva Med; 1997; 88(7-8):307-10. PubMed ID: 9304074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fingertip necrosis in a 6-year-old child with primary Raynaud's phenomenon.
    Bhat W; Akhtar S; Knight S
    J Hand Surg Eur Vol; 2012 May; 37(4):363-5. PubMed ID: 22190563
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).
    Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Peltier AP
    Ann Rheum Dis; 1978 Aug; 37(4):321-7. PubMed ID: 308354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactive hyperemia in Raynaud's disease.
    Pratesi F; Corsi C; Deidda C; Nuti A
    Biochem Exp Biol; 1977; 13(3):337-9. PubMed ID: 16296018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic (im)possibilities in Raynaud's phenomenon].
    Smilde TJ; Wollersheim H
    Ned Tijdschr Geneeskd; 1996 Feb; 140(7):352-7. PubMed ID: 8628419
    [No Abstract]   [Full Text] [Related]  

  • 28. Collagenosis and Raynaud phenomenon.
    Allen HB
    Arch Dermatol; 1973 Apr; 107(4):621-2. PubMed ID: 4697696
    [No Abstract]   [Full Text] [Related]  

  • 29. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M; Hirschl K; Lenz M; Katzenschlager R; Hutter HP; Kundi M
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Raynaud's phenomenon in early childhood.
    Herrick AL; Jayson MI
    Br J Rheumatol; 1991 Jun; 30(3):223-5. PubMed ID: 2049587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thermoregulation and Raynaud's phenomenon.
    Downey JA; LeRoy EC; Miller JM; Darling RC
    Clin Sci; 1971 Mar; 40(3):211-9. PubMed ID: 5550898
    [No Abstract]   [Full Text] [Related]  

  • 32. [Dermatology and internal medicine from the view of vascular surgery--collagenic Raynaud's syndrome].
    Tsunekawa K; Yamamoto K; Moori K; Hirooka M; Ikeda M
    Saishin Igaku; 1966 Oct; 21(10):2156-63. PubMed ID: 5977765
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-cardiolipin antibodies, Raynaud's phenomenon with digital ischemia, and non small cell carcinoma of the lung.
    Vaidya S; Logan JW
    Scand J Rheumatol; 2001; 30(3):172-4. PubMed ID: 11469530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins.
    Reeves WH; Fisher DE; Wisniewolski R; Gottlieb AB; Chiorazzi N
    N Engl J Med; 1986 Jul; 315(2):105-11. PubMed ID: 2941686
    [No Abstract]   [Full Text] [Related]  

  • 35. [Raynaud's disease and phenomenon (author's transl)].
    González Folch M
    Rev Med Chil; 1976 Jan; 104(1):47-51. PubMed ID: 968221
    [No Abstract]   [Full Text] [Related]  

  • 36. Psoriasis and Raynaud's phenomenon with antiribonucleoprotein antibodies.
    Kallenberg CG; de Rooij DJ; van Venrooij WJ
    N Engl J Med; 1987 Jan; 316(2):111-2. PubMed ID: 3785356
    [No Abstract]   [Full Text] [Related]  

  • 37. Raynaud's phenomenon and positive antinuclear antibodies in a malignancy.
    Tolosa-Vilella C; Ordi-Ros J; Vilardell-Tarres M; Selva-O'Callaghan A; Jordana-Comajuncosa R
    Ann Rheum Dis; 1990 Nov; 49(11):935-6. PubMed ID: 2256742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Raynaud's phenomenon.
    Herrick AL
    Rheumatology (Oxford); 2005 May; 44(5):587-96. PubMed ID: 15741200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of Raynaud's disease with uterine cancer producing interleukin-6.
    Murashima A; Takasaki Y; Hashimoto H; Hirano T; Hirose S
    Clin Rheumatol; 1992 Sep; 11(3):410-2. PubMed ID: 1458793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Raynaud's phenomenon.
    García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R
    Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.